Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc.（ADVM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
advm · 股价预测 · 16 位分析师（近3月）· FMP · 更新于 2026年2月12日
分析师评级与共识
基于过去 3 个月内 16 位华尔街分析师
Buy
16 位分析师
共识
评级分布
12 个月目标价
High
$28.00
Consensus
$8.90
+104.1% upside
Low
$2.00
Median: $5 · Last Close: $4.36
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$8.90
104.1% upside
High Target
$28
542.2%
Low Target
$2
-54.1%
Current Price
$4.36
as of today
Based on analyst price targets, the ADVM stock price prediction for the next 12 months ranges from $2 to $28. The consensus ADVM price forecast of $8.90 implies 104.1% upside from the current price of $4.36.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $4.39 | ↑ 0.58% |
1-day model range: $4.38–$4.39. Peak: $4.39 (+0.58%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $3 | -32.8% |
| 2028 | $2 | -43.8% |
| 2029 | $2 | -48.4% |
| 2030 | $2 | -50.5% |
| 2031 | — | -51.5% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ADVM · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-17 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-10-28 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-09-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | Chardan Capital | Maintains | Buy→Buy |
| 2025-06-26 | Mizuho | Maintains | Outperform→Outperform |
| 2025-05-15 | Chardan Capital | Maintains | Buy→Buy |
| 2025-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-15 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-04-17 | Chardan Capital | Maintains | Buy→Buy |
| 2025-04-16 | RBC Capital | Maintains | Sector Perform→Sector Perform |
Wall Street analysts have recently issued updated ratings on Adverum Biotechnologies, Inc. (ADVM) stock. Of the recent 70 rating actions, 7 were upgrades and 13 were downgrades. 16 analysts currently cover ADVM.
分析师推荐趋势
ADVM analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 99.6% YoY
Revenue Next Year
$15M
↑ 7500.0% YoY
EPS This Year
$-8.04
EPS Next Year
$-4.83
↓ 40.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ADVM EPS of $-8.04 for the current fiscal year, based on estimates from 2 analysts. The ADVM revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ADVM 股价预测由两类独立数据源支撑：来自 16 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ADVM 的共识目标价为 $8.90（+104.1% 上行空间），分析师共识为 Buy。
ADVM 的短期预测（明日）为 $4.39（+0.58%）。 ADVM 对 2027 年的股价预测均值为 $3。 ADVM 对 2030 年的预测区间为 $2–$2。
Adverum Biotechnologies, Inc. 在 NASDAQ 上市，代码 ADVM。ADVM 在 2027 年的整体展望偏积极，在覆盖分析师中约 63% 对应 Buy 共识。
常见问题
ADVM 预测 · 8 个问题根据 16 位华尔街分析师，ADVM 的 12 个月平均目标价为 $8.90，最高 $28.00、最低 $2.00。若有图表，中位目标价可在上方查看。相对当前价 $4.36，隐含约 +104.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.